Michael Rink

12.2k total citations · 1 hit paper
230 papers, 5.2k citations indexed

About

Michael Rink is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Rink has authored 230 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Surgery, 79 papers in Urology and 74 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Rink's work include Bladder and Urothelial Cancer Treatments (147 papers), Urinary and Genital Oncology Studies (112 papers) and Urological Disorders and Treatments (65 papers). Michael Rink is often cited by papers focused on Bladder and Urothelial Cancer Treatments (147 papers), Urinary and Genital Oncology Studies (112 papers) and Urological Disorders and Treatments (65 papers). Michael Rink collaborates with scholars based in Germany, United States and Austria. Michael Rink's co-authors include Shahrokh F. Shariat, Pierre I. Karakiewicz, Évanguelos Xylinas, Felix K.‐H. Chun, Armin Soave, Luis A. Kluth, Roland Dahlem, Douglas S. Scherr, Margit Fisch and Yair Lotan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Michael Rink

218 papers receiving 5.1k citations

Hit Papers

Epidemiology, diagnosis, preoperative evaluation and prog... 2016 2026 2019 2022 2016 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
    2016 261 citations Francesco Soria, Shahrokh F. Shariat et al. World Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Rink Germany 39 3.6k 1.4k 1.3k 1.1k 735 230 5.2k
Évanguelos Xylinas France 40 4.2k 1.2× 1.8k 1.3× 1.2k 1.0× 1.1k 1.0× 810 1.1× 227 5.7k
Luis A. Kluth Germany 34 2.6k 0.7× 1.4k 1.0× 930 0.7× 1.3k 1.2× 390 0.5× 237 4.1k
Hendrik Isbarn Germany 44 2.7k 0.8× 2.6k 1.9× 680 0.5× 910 0.8× 946 1.3× 159 5.2k
Giovanni Lughezzani Italy 45 2.7k 0.7× 3.4k 2.4× 737 0.6× 1.2k 1.1× 1.0k 1.4× 276 5.8k
Christian Bolenz Germany 27 2.4k 0.7× 1.1k 0.8× 701 0.6× 698 0.6× 611 0.8× 213 3.5k
Aditya Bagrodia United States 35 2.8k 0.8× 2.2k 1.6× 610 0.5× 547 0.5× 926 1.3× 244 4.5k
Dipen J. Parekh United States 35 1.7k 0.5× 1.8k 1.3× 462 0.4× 1.0k 0.9× 662 0.9× 192 3.9k
Erik P. Castle United States 37 2.0k 0.6× 2.0k 1.4× 593 0.5× 933 0.8× 524 0.7× 163 4.0k
Hanjong Ahn South Korea 35 1.8k 0.5× 3.2k 2.2× 574 0.5× 746 0.7× 1.3k 1.8× 306 4.8k
C.C. Abbou France 40 2.3k 0.6× 2.5k 1.8× 678 0.5× 521 0.5× 2.0k 2.8× 139 5.0k

Countries citing papers authored by Michael Rink

Since Specialization
Citations

This map shows the geographic impact of Michael Rink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rink more than expected).

Fields of papers citing papers by Michael Rink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rink. The network helps show where Michael Rink may publish in the future.

Co-authorship network of co-authors of Michael Rink

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rink. A scholar is included among the top collaborators of Michael Rink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rink. Michael Rink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kluth, Martina, Maximilian Lennartz, Niclas C. Blessin, et al.. (2023). MYC amplifications are a common event in urothelial bladder carcinomas associated with an aggressive tumor phenotype. American Journal of Clinical Pathology. 160(Supplement_1). S91–S92. 1 indexed citations
2.
Deimling, Markus von, Michael Rink, Jakob Klemm, et al.. (2022). Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy. British Journal of Urology. 131(1). 90–100. 3 indexed citations
3.
Gild, Philipp, Malte W. Vetterlein, Tim A. Ludwig, et al.. (2022). Which Men Do or Do Not Achieve Long-Term Symptom Relief After Holmium Laser Enucleation of the Prostate (HoLEP): 11 Years of HoLEP Experience. Journal of Endourology. 37(3). 316–322. 3 indexed citations
4.
Janisch, Florian, Phillip Marks, Christian P. Meyer, et al.. (2021). Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data. Frontiers in Surgery. 8. 3 indexed citations
5.
Schuettfort, Victor M., Benjamin Pradère, Fahad Quhal, et al.. (2020). Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinoma. SHILAP Revista de lepidopterología. 47(1). S33–S44. 2 indexed citations
6.
Vetterlein, Malte W., Michael Rink, Silke Riechardt, et al.. (2020). Longitudinal Evaluation of Perineogenital Pain and Postoperative Complications After One-stage Buccal Mucosal Graft Urethroplasty: A Secondary Analysis of a Randomized Controlled Trial. European Urology Focus. 7(5). 1157–1165. 6 indexed citations
7.
Janisch, Florian, David D‘Andrea, Takehiro Iwata, et al.. (2020). The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC). Urologic Oncology Seminars and Original Investigations. 38(5). 423–432. 7 indexed citations
8.
Abufaraj, Mohammad, Shoji Kimura, Andrea Haitel, et al.. (2020). The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy. Urologic Oncology Seminars and Original Investigations. 38(8). 685.e17–685.e25. 2 indexed citations
9.
Janisch, Florian, Mohammad Abufaraj, Harun Fajković, et al.. (2019). Current Disease Management of Primary Urethral Carcinoma. European Urology Focus. 5(5). 722–734. 27 indexed citations
10.
Kimura, Shoji, Francesco Soria, David D‘Andrea, et al.. (2018). Prognostic Value of Serum Cholinesterase in Non–muscle-invasive Bladder Cancer. Clinical Genitourinary Cancer. 16(6). e1123–e1132. 17 indexed citations
11.
Kimura, Shoji, Francesco Soria, Beat Foerster, et al.. (2018). Prognostic value of modified Glasgow Prognostic Score in non–muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 37(3). 179.e19–179.e28. 19 indexed citations
12.
Foerster, Beat, Marco Moschini, Mohammad Abufaraj, et al.. (2017). Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma. Clinical Genitourinary Cancer. 15(6). e1039–e1045. 11 indexed citations
13.
Vetterlein, Malte W., Philipp Gild, Luis A. Kluth, et al.. (2017). Peri‐operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score‐weighted European multicentre study. British Journal of Urology. 121(1). 101–110. 16 indexed citations
14.
Aziz, Atiqullah, Jakub Dobruch, Kees Hendricksen, et al.. (2017). Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review. World Journal of Urology. 35(9). 1401–1407. 22 indexed citations
15.
Soave, Armin, Roland Dahlem, Hans O. Pinnschmidt, et al.. (2017). Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and Morbidity. European Urology. 73(6). 910–922. 35 indexed citations
16.
Soria, Francesco, Ilaria Lucca, Marco Moschini, et al.. (2017). Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer. Urologic Oncology Seminars and Original Investigations. 35(6). 356–362. 4 indexed citations
17.
Green, David A., E. Charles Osterberg, Évanguelos Xylinas, et al.. (2012). HERRAMIENTAS PREDICTORAS DEL ESTADIAJE DEL CÁNCER DE PRÓSTATA, RESPUESTA AL TRATAMIENTO Y RESULTADOS. Archivos Españoles de Urología. 65(9). 787–807. 1 indexed citations
18.
Green, David A., M. Durand, Naveen Gumpeni, et al.. (2012). Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. British Journal of Urology. 110(10). 1463–1470. 38 indexed citations
19.
Bednarz‐Knoll, Natalia, Elke Eltze, Axel Semjonow, et al.. (2010). BRCA1 Loss Preexisting in Small Subpopulations of Prostate Cancer Is Associated with Advanced Disease and Metastatic Spread to Lymph Nodes and Peripheral Blood. Clinical Cancer Research. 16(13). 3340–3348. 53 indexed citations
20.
Lansky, Alexandra J., Roxana Mehran, Yoshihiro Tsuchiya, et al.. (2004). 1059-6 The multicenter evaluation of the everolimus-eluting stent for inhibition of neointimal hyperplasia: Results of the pooled FUTURE I and II trials. Journal of the American College of Cardiology. 43(5). A12–A12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Évanguelos Xylinas Breakdown of academic impact, for papers by Luis A. Kluth Breakdown of academic impact, for papers by Hendrik Isbarn Breakdown of academic impact, for papers by Giovanni Lughezzani Breakdown of academic impact, for papers by Christian Bolenz Breakdown of academic impact, for papers by Aditya Bagrodia Breakdown of academic impact, for papers by Dipen J. Parekh Breakdown of academic impact, for papers by Erik P. Castle Breakdown of academic impact, for papers by Hanjong Ahn Breakdown of academic impact, for papers by C.C. Abbou
Rankless by CCL
2026